IL33 and COVID-19: The facts that the levels of IL‐33 and ATP are elevated in patients with COVID‐19 and that the activation status of MCs correlates with the severity of COVID‐19 [13, 14] indicate that the principle of ATP/IL‐33 co‐sensing might also be relevant for the development of severe COVID‐19.